
Type of position: Seconded National Expert
Reference: EMA/SNE/11507
Job title: SNE/Scientific Specialist
Deadline for applications: 25 June 2026 at 23.59 CET
The European Medicines Agency is a decentralized body of the European Union with all its offices and Headquarters based in Amsterdam, the Netherlands. Its core responsibility is the protection and promotion of public health through the evaluation and supervision of medicines.
We are looking for National experts on secondment. This means staff from other European public-sector bodies can work at the European Medicines Agency (EMA) for short periods of time through the national expert on secondment (SNE) programme. The aim of this programme is to enhance and develop the relationship between European public administrations.
SNEs serve a dual role: they bring their expertise to EMA and take back to their home administration the knowledge acquired during their period of secondment. SNEs remain in the service of their employer. Secondment is not equivalent to employment, nor does it lead to employment by EMA. Periods of secondment may last between six months and two years. This is renewable once or more, up to a total of four years.
This announcement is governed by the Rules governing the secondment of national experts. For further information please visit our Careers portal.
The Agency is looking to strengthen the support it provides to clinical trials through the secondment of national experts for a period of one to two years (renewable). The Agency is working with the National Competent Authorities (NCAs) for medicines and the European Commission to optimise the EU clinical trials environment and this is being coordinated through Accelerating Clinical Trials in the EU (ACT EU) the EU transformation programme for clinical trials. EMA also operates and develops the Clinical Trials Information System (CTIS) and works with the NCAs and the Commission on the implementation of the Clinical Trials Regulation (CTR) including support to the Clinical Trials Coordination Group (CTCG).
Depending on the specific role, the position may involve:
Working within the EMA Data Analytics and Methods Task Force you will be part of multidisciplinary teams at EMA and across the National Competent Authorities and European Commission. You will contribute to strengthening and transforming the European clinical trials environment, supporting key regulatory, scientific, and operational activities.
Depending on the specific position, you may:
Education
Field of study
Life Science (e.g. biology, chemistry, biochemistry, pharmacy).
Experience
Skills & Knowledge
Education
Field of study
Experience
Timelines
Deadline for applications 24 June 2026 at 23:59 CET
Interviews From 01 July 2026
Decision expected 13 July 2026
Process
This post is published in line with Chapter II Art 4 of EMA/329753/2015 (European Medicines Agency Decision of 30 June 2015 laying down general implementing provisions on the procedure governing the engagement and use of temporary staff under Article 2(f) of the Conditions of Employment of Other Servants of the European Union).
The process will follow Annex I of Guidance on Internal Talent Marketplace.
Only eligible candidates (see eligibility criteria (i.e. temporary staff 2(f) who, on the closing date for applications and on the day of filling the post, are engaged within the agency in the function group and grade belonging to the grade bracket indicated in the internal publication.) will be assessed further.
The assessment of qualifications and suitability will be based solely on the required competencies, skills, knowledge, qualifications and experience for the role as stated in the internal publication.
Shortlisting
Talent Acquisition may publish additional pre-screening questions but, normally, the initial assessment will be conducted based on the application form submitted for an opening, and all eligible staff will be invited for a follow up assessment
Assessments
The assessments will include at the very least interviews and, only in specific circumstances, a written test, to identify the most suitable candidate.
In case of Head of Service roles, personality assessment or assessment of managerial competencies via assessment centre will be conducted.
Job offers
This publication is intended to fill a specific vacancy(ies), therefore, as a result of the assessments, the Selection Committee will recommend to the Executive Director the best candidate for the appointment, plus it may recommend 2-3 alternates from among those were found qualified and suitable for the specific vacancy in question. An additional interview with the hiring entity may be arranged before the final decision to recruit the candidate. Alternate candidates may be offered a position in case the initially selected candidate cannot take up the offer or their employment is not confirmed after probation period, but they are not placed in any reserve list. Alternate candidates may be appointed to other similar vacant post based on Art 7 of Staff Regulations.
The selected candidate, as well as all alternates, will be informed accordingly of the result of the internal publication.
Conditions of employment
The selected member of temporary staff 2(f) shall be assigned to the new post by written decision of the Executive Director without impact on his/her current contract of employment with the agency.
______________________________________________________________________________________________________
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
© European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged.

The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.